InvestorsHub on MSN

Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis

Biofrontera Inc. (NASDAQ:BFRI) said on Monday that its Phase 3 clinical study of Ameluz photodynamic therapy (PDT) successfully achieved its primary endpoint in the treatment of actinic keratoses ...
The Manila Times

Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines

Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 ...
Hosted on MSN

Veracyte reports Phase 3 STAMPEDE trial finding published in Cell

Veracyte (VCYT) and University College London announced that data published online in Cell show that the Decipher Prostate Genomic Classifier predicts which patients with metastatic cancer are likely ...
Seeking Alpha

Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout

Abviax's Obefazimod shows promising phase 2b results in ulcerative colitis, with superior safety and efficacy compared to existing treatments, supporting a buy rating. The drug's novel mechanism ...
EurekAlert!

Mount Sinai dermatologist reports Phase 3 success for rocatinlimab in moderate-to-severe eczema

New York, NY (November 25, 2025) – An international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of ...
Nasdaq

Rhythm Pharmaceuticals Reports Positive Phase 2 Trial Results for Bivamelagon in Acquired Hypothalamic Obesity with Significant BMI Reductions

Bivamelagon showed significant BMI reductions in hypothalamic obesity patients, prompting Rhythm Pharmaceuticals to seek FDA guidance for Phase 3 trials. Rhythm Pharmaceuticals, Inc. announced ...